Systematic review / meta-analysis / 2018
Magnesium shows Grade C evidence as a possibly effective migraine prophylactic.
A systematic review synthesized five randomized, double-blind, placebo-controlled trials assessing prophylactic magnesium in adults aged 18 to 65. One of two Class I trials and two of three Class III trials detected a statistically significant drop in migraine attacks or primary efficacy measures versus placebo. The authors concluded that current evidence supports magnesium as possibly effective for migraine prevention.
- Study type
- Systematic review of randomized controlled trials
- Who was studied
- 5 randomized placebo-controlled trials, adults aged 18-65 with migraine
- What was measured
- Migraine days and attack frequency
THE PAPER
Magnesium in Migraine Prophylaxis-Is There an Evidence-Based Rationale? A Systematic Review.
von Luckner A, Riederer F. Headache, 2018.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.